Pharmacological treatment of acute variceal bleeding

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 28-36

  Burroughs, A K ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cirrhosis; Octreotide; Somatostatin; Terlipressin; Variceal bleeding

Indexed keywords

DOMPERIDONE; METOCLOPRAMIDE; OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL;

DOMPERIDONE; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; LYSINE VASOPRESSIN; METOCLOPRAMIDE; OCTREOTIDE; RANDOMIZED CONTROLLED TRIALS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SOMATOSTATIN; VASOPRESSINS;

EID: 0031855774     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051417     Document Type: Conference Paper

References (91)

1. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytical review. Hepatology 1995;22:332-354.
2. Smith JL, Graham DY: Variceal haemorrhage: A critical evaluation of survival analysis. Gastroenterology 1982;82:968-973.
3. Burroughs AK, Mezzanotte G, Phillips A et al: Cirrhotic with variceal haemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989;9:801-807.
4. Thomsen BL, Moller S, Sorensen T and the Copenhagen Esophageal Varices Sclerotherapy Project: Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Hepatology 1994;21:367-375.
5. Christensen E, Fauerholdt L, Schlichting P et al: Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effects of prednisolone. Gastroenterology 1981;81:944-952.
6. Graham DY, Smith JL: The course of patients after variceal haemorrhage. Gastroenterology 1981;80:800-809
7. DeDombal FT, Clarke JR, Clamp SE, Mallzia G, Kohval MR, Morgan AG: Prognostic factors in upper GI bleeding. Endoscopy 1986;18 (suppl):6-10.
8. Spence RAJ: Surgical measures for active variceal bleeding. Gastrointest Endosc 1992;2:77-94.
9. Pourriat JL, Levacher S, Letoumelin P, Blaise M: Early administration of the association terlipressin-nitroglycerin in cirrhotic active digestive bleeding. Hepatology 1994;19:4:312A.
10. Sung JY, Chung S, Lai CW et al: Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993;342:657-641.
11. Morillas R, Quer JC, Planas R et al: Somatostatin vs endoscopic sclerotherapy in the treatment of acute variceal bleeding: Final results of a prospective randomized trial. Hepatology 1994; 19:1051.
12. Variceal Bleeding Study Group: Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following variceal haemorrhage in patients with cirrhosis. Hepatology 1994;19:1361.
13. Del Arbol R, de Argila M, Vasquez C et al: Endoscopic measurement of variceal pressure during haemorrhage from eosophageal varices. Hepatology 1992;16:81A.
14. Ready JB, Robertson AD, Goff JS, Rector G: Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology 1991;100: 1403-1410.
15. Clanet J, Tounet R, Roubuier C et al: Traitement par la pitressine des hémorragies par rupture de varices œsophagiennes chez les cirrhotiques. Acta Gastroenterol Belg 1978;41:539-543.
16. Correia JP, Alves MM, Alexandrio P et al: Controlled trial of vasopressin and balloon tamponade in bleeding esophageal varices. Hepatology 1984;4:885-888.
17. Merigan TC Jr, Poltkin JR, Davidson CS: Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. N Engl J Med 1962;266: 134-135.
18. Johnson WC, Wildrich WC, Ansell JE et al: Control of bleeding varices by vasopressin: A prospective randomized study. Ann Surg 1977;186:269-27.
19. Chojkier M, Groszman RJ, Atterbury CE et al: A controlled comparison of continuous intra-arterial and intravenous infusions of vasopressin in haemorrhage from esophageal varices. Acta Gastroenterol Belg 1979;41:539-543.
20. Fogel MR, Knauer CM, Andress LE: Continuous intravenous vasopressin in active upper gastrointestinal bleeding. A placebo-controlled trial. Ann Intern Med 1982;96:565-569.
21. Freeman JG, Eishman AH, Cobden I et al: Controlled trial of terlipressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet 1982;ii:266-268.
22. Kravetz D, Bosch J, Teres J et al: Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal haemorrhage. Hepatology 1984;4:442-446.
23. Jenkins SA, Baxter JN, Corbett W et al: A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J 1985;290:275-278.
24. Conn HO, Ramsby GR, Storer EH et al: Intra-arterial vasopressin in the treatment of upper gastrointestinal haemorrhage: A prospective, controlled clinical trial. Gastroenterology 1975; 68:211-221.
25. Mallory A, Schaefer JE, Cohen JR: Selective intra-arterial vasopressin infusion for upper gastrointestinal tract haemorrhage. A controlled trial. Arch Surg 1980;115:30-32.
26. Hsia HC, Lee FY, Tsai YT et al: Comparison of somatostatin and vasopressin in the control of acute esophageal variceal haemorrhage: A randomized controlled study. Chin J Gastroenterol 1990;7:71-78.
27. Hwang SJ, Lin HC, Chang CF et al: A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992;16:320-325.
28. Bagarani M, Albertini V, Anza M et al: Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci 1987;172-176.
29. Saari A, Elvilaakso Em Inberg M et al: Comparison of somatostatin and vasopressin bleeding esophageal varices. Am J Gastroenterol 1990; 804-807.
30. D'Amico G, Traina M, Vizzini G et al: Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomised clinical trial. J Hepatol 1994;20:206-212.
31. Johnson WC, Widrich WC, Ansell JE, Robbins AH, Nasbeth DC: Control of bleeding varices by vasopressin: A prospective randomized trial. Ann Surg 1977;186:369-376.
32. Bosch J, Groszman RJ, Garcia-Pagan JC et al: Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal haemorrhage: A placebo-controlled clinical trial. Hepatology 1989;10:962-968.
33. Gimson AES, Westaby D, Hegarty J, Alastair W, Williams R: A randomized trial of vasopressin plus nitroglycerin in the control of acute variceal haemorrhage. Hepatology 1986;6:410-413.
34. Tsai YT, Lay CS, Lai KH et al: Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding oesophageal varices. Hepatology 1986;6:406-409.
35. Soderlund C, Magnusson I, Torngren S et al: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990;25:622-630.
36. Freeman JG, Cobden I, Record CO: Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989;11:58-60.
37. Walker S, Stiehl A, Raedseh R et al: Terlipressin in bleeding oesopheal varices: A placebo controlled double-blind study. Hepatology 1986;6: 112-115.
38. Aracidiacono R, Biraghi M, Bonomo GM, Fiaccadori F: Randomised controlled trial with terlipressin in cirrhotic patients with bleeding oesophageal varices: Effects on precocious rebleeding and mortality rates. Curr Ther Res 1992;52:186-194.
39. Freeman JG, Cobden I, Lishman AH, Record CO: Controlled trial of terlipressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet 1982;ii:66-68.
40. Desaint B, Florent C, Levy VG: A randomized trial of triglycyl-lysine vasopressin versus lysine vasopressin in active cirrhotic variceal haemorrhage; in Lebrec D, Blei AT (eds): Vasopressin Analogs and Portal Hypertension. Paris, Libbey, 1987, pp 155-157.
41. Lee YF, Tsay YT, Lai KH et al: A randomized controlled study of triglycl-vasopressin and vasopressin in the control of bleeding from oesophageal varices. J Gastroenterol Hepatol 1990;5:549-553.
42. Chiu WK, Sheen IS, Liaw YF: A controlled study of glypressin versus vasopressin in the control of acute oesophageal variceal haemorrhage. J Gastroenterol Hepatol 1990;5:549-553.
43. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL: Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865-868.
44. Burroughs AK, Patch D: Hepatology elsewhere. Therapeutic benefit of vasoactive drugs for acute variceal bleeding: A real pharmacological effect of a side effect of definition in trials. Hepatology 1996;22:737-739.
45. Wahren J, Fleig G: Influence of somatostatin on carbohydrate disposal and absortion in diabetes mellitus. Lancet 1976;ii:1213-1216.
46. Sonnenburg GE, Keller U, Perruchud A, Burckhardt et al: Effect of somatostatin on splanchnic haemodynamics. Gastroenterology 1981;80: 5226-5232.
47. Tyden G, Samnegaard H, Thulin L, Muhrbeck O, Efendic S: Circulatory effects of somatostatin in anaesthetized man. Acta Chir Scand 1979; 145:443-446.
48. Merkel C, Gatta A, Zuin R, Finucci GF, Arnaboldi L, Roul A: Effect of somatostain on splanchnic haemodynamics in patients with liver cirrhosis and portal hypertension. Digestion 1985;32:92-98.
49. Bosch J, Kravetz D, Rodes J: Effects of somatostatin on hepatic and systemic haemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981; 80:518-525.
50. Bories P, Pomler-Layrargues G, Chotard JP, Jacob C, Michel H: Somatostatin reduces portal hypertension in cirrhotic patients. Gastroenterol Clin Biol 1980;4:616-617.
51. Eriksson LS, Law DH, Wahren J: Influence of somatostain on splanchnic haemodynamics in patients with liver cirrhosis. Clin Physiol 1984; 4:5-11.
52. Mastai R, Bosch J, Navasa M et al: Effects of continuous infusion and bolus injections of somatostatin on azygous blood flow and hepatic and systemic haemodynamics in patients with portal hypertension: Comparison with vasopressin (abstract). J Hepatol 1986;3(suppl 1):53.
53. Sonnenberg A, West C: Somatostatin reduced gastric mucosal flow in normal subjects but not in patients with cirrhosis of the liver. Gut 1983; 24:148-153.
54. Kleber G, Sauerbruch T, Fischer G, Paumgartner G: Somatostatin does not reduce oesophageal variceal pressure in liver cirrhosis. Gut 1988;29:153-156.
55. Cirera I, Feu F, Garcia-Pagan A et al: Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind haemodynamic investigation. Hepatology 1995;22:106-111.
56. Jenkins SA, Baxter JN, Snowden S: The effects of somatostatin and SMS 201-995 on hepatic and systemic haemodynamics in patients with cirrhosis and portal hypertension. Fibrinolysis 1988;2:48-50.
57. McKee RK, Pringle SD, Garden OJ et al: SMS 201-995 in the management of variceal bleeding. Gut 1989;28:A1380.
58. Jenkins SA, Baxter JN, Corbett WA et al: Effects of somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man. Br J Surg 1985;72:1009-1012.
59. Navasa M, Bosch J, Chesta J et al: Haemodynamic effects of subcutaneous administration of SMS 201-995, a long-acting somatostatin analogue, in patients with cirrhosis and portal hypertension. Hepatology 1988;7:123.
60. Avgerinos A, Klonis C, Rekoumis G et al: A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol 1991; 13:78-83.
61. Cardona C, Vida F, Balanzo J et al: Eficacia terapeutica de la somatostatina versus vasopresina mas nitroglicerina en la hemorragia activa por varices esofagogastricas. Gastroenterol Hepatol 1989;12:30-34.
62. McKee R: A study of octreotide in oesophageal varices. Digestion 1990;45(suppl 1):60-65.
63. Jaramillo JL, de la Mata M, Mino G et al: Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. J Hepatol 1991;12:100-105.
64. Valenzuela JE, Schubert T, Fogel MR et al: A multicenter, randomized, double-blind trial of somatostatin in the management of acute haemorrhage from esophageal varices. Hepatology 1989;10:958-961.
65. Burroughs AK, McCormick PA, Hughes MD et al: Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990;99: 1388-1395.
66. Jenkins SA, Yates J, Baxter JN et al: A prospective randomized controlled clinical trial comparing sandostatin and injection sclerotherapy in the control of acute variceal haemorrhage: An interim report. Gut 1992;23(suppl 1):F233.
67. Variceal Bleeding Study Group: Glypressin vs somatostatin in the treatment of acute variceal bleeding in patients with cirrhosis. A double-blind randomized controlled trial. Hepatology 1994;19:1361.
68. Silvain C, Carpenter S, Savereau D et al: Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 1993;18:61-65.
69. Walker S, Kreichgauer H-P, Bode JC et al: Terlipressin vs somatostatin in bleeding esophageal varices: A controlled, double-blind study. Hepatology 1992;15:1023-1030.
70. Shields R, Jenkins SA, Kingsworth AN et al: A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 1992;16:128-137.
71. Di Febo G, Siringo S, Vacirca M et al: Somatostatin and urgent sclerotherapy in active oesophageal variceal bleeding. Gastroenterology 1990;99:A583.
72. Gotzche P, Gjorup I, Bonnen H, Brahe N, Becker U, Burcharth F. Somatostatin versus placebo in bleeding oesophageal varices: Randomized trial and meta-analysis. Br J Med 1995; 1495-1498.
73. Feu F, Del Arbol LR, Banares R et al: Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal haemorrhage. Gastroenterology 1996;111: 1291-1299.
74. Besson I, Ingrand P, Person B, Boutroux D, Denis H, Bernard P: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-560.
75. Sung JYC, Chung SCS, Yung MY et al: Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-1669.
76. Averginos A, Nevens F, Raptis S, Fevery J, Adler M, Armonis A et al: Early administration of natural somatostatin increases the efficacy of sclerotherapy in acute bleeding oesophageal variceal episodes. The European ABOVE study. Gut 1996;39(suppl 3).
77. Burroughs AK for the International Octreotide Varices Group: Double-blind RCT of 5-day octreotide versus placebo associated with sclerotherapy for trial failures (abstract). Hepatology 1996;24:352A.
78. Taranto D, Suozzo R, de Sio I et al: Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Digestion 1990;47:56-60.
79. Hosking SW, Doss W, El-Einy H et al: Pharmacological constriction of the lower esophageal sphincter: A simple method of arresting variceal haemorrhage. Gut 1990;29:1098-1102.
80. Feu F, Mas A, Bosch J et al: Domperidone or metoclopramide versus placebo in the prevention of early variceal re-bleeding in cirrhosis. A prospective randomized trial (abstract). J Hepatol 1988;7(suppl 1):531.
81. Pmto-Correia J, Malies M, Alexandrino P, Silveira J: Controlled trial of vasopressin and balloon tamponade in bleeding oesophageal varices. Hepatology 1984;4:885-888.
82. Colin R, Giuli N, Czernichow P, Ducrotte P, Lerebours E: Prospective comparison of glypressin, tamponade and their association in the treatment of bleeding esophageal varices; in Lebrec D, Blei AT (eds): Vasopressin Analogs and Portal Hypertension. Paris, Libbey, 1987, pp 149-153.
83. Fort E, Sautereau D, Silvain C, Ingrand P, Pillogand B, Beauchant M: A randomized trial of terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal hemorrhage. Hepatology 1990;11:678-681.
84. Teres J, Planas R, Panes J et al: Vasopressin/ nitroglycerin infusion vs oesophageal tamponade in the treatment of acute variceal bleeding. A randomized controlled trial. Hepatology 1990;11:964-968.
85. Blanc P, Bories J, Desperez D et al: Balloon tamponade with Linton-Michel tube versus terlipressin in the treatment of acute oesophageal and gastric variceal bleeding. J Hepatol 1994;21:S133.
86. Westaby D, Hayes PC, Gimson AES, Polson RJ, Williams R: Controlled trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989;9:274-277.
87. Alexandrino P, Alves MM, Fidalgo P et al: Is sclerotherapy the first choice treatment for active oesophageal varical bleeding in cirrhotic patients? J Hepatol 1990;11:S1.
88. The Copenhagen Oesophageal Varices Sclerotherapy Project: Sclerotherapy after first variceal haemorrhage in cirrhosis. A randomized multicentre trial. N Engl J Med 1984;311:1594-1600.
89. Larson AW, Cohen H, Zweilan B et al: Acute oesophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. JAMA 1986;255:497-500.
90. Soderlund C, Hue T: Endoscopic sclerotherapy vs conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment. Acta Chir Scand 1985;151:499-456.
91. Lebrec D, Novel O, Corbic M et al: Propranolol - A medical treatment for portal hypertension. Lancet 1980;2:180-182.